As of 2026-09-17, the Fair Value of Briacell Therapeutics Corp (BCT.TO) is -17.63 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.98 CAD, the upside of Briacell Therapeutics Corp is -454.00%.
With the market price of 4.98 CAD and our fair value calculation, Briacell Therapeutics Corp (BCT.TO) is not a good investment. Investing in BCT.TO stocks now will result in a potential loss of 454.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | 5Y Avg | |
| Net income | -13.82 | -26.84 | -20.30 | -4.79 | -26.31 | -18.41 |
| YoY growth | -279.76% | -94.26% | 24.35% | 76.40% | -449.14% | -144.48% |
| Market Cap (mil) | 43.33 |
| P/E | |
| Forward P/E |
| EPS | -3.53 |
| Avg earnings growth rate | -144.48% |
| TTM earnings | -30.68 |